Lupin, on Tuesday, announced the launch of Tydemy tablets – the generic equivalent of Bayer's Safyral, a birth control drug. The pharma major stated that it had received US Food and Drug Administration's (USFDA) approval in December last year.Tydemy (drospirenone, ethinyl estradiol, levomefolate calcium, 3mg/0.03mg/0.451mg & levomefolate calcium, 0.451mg) is the generic version of Safyral, which is indicated for use by women to prevent pregnancy and raise folate levels in women who choose to use oral contraceptives. This combination formulation had an annual sale of approximately $22mn in the US in 2017. Apart from Lupin, there seems only one player in this market.
CapitalStars Award Winning , SEBI registered , ISO certified investment advisory company. We provide intraday & positional services in Equity , derivative ,commodity & currency. Our research is highly skilled & experienced .
Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
No comments:
Post a Comment